An Open Label, Dose Escalation Study of ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects
Latest Information Update: 08 Nov 2016
Price :
$35 *
At a glance
- Drugs ACH 04 (Primary)
- Indications Diarrhoea
- Focus Adverse reactions; First in man
- Sponsors Ache Laboratories
- 08 Nov 2016 New trial record